Literature DB >> 3946174

The usefulness of dobutamine in the assessment of the severity of mitral stenosis.

M H Hwang, I Pacold, Z E Piao, R Engelmeier, P J Scanlon, H S Loeb.   

Abstract

Patients with mitral stenosis often require supine exercise in order to increase their heart rate and cardiac output to assess the severity of their valvular obstruction during cardiac catheterization. We substituted dobutamine for exercise in 14 patients with suspected mitral stenosis. The dobutamine infusion was started at 5 micrograms/kg/min and was increased to 10, 15, and 20 micrograms/kg/min every 3 minutes as tolerated. The heart rate increased from 84 +/- 4 to 123 +/- 7 bpm (p less than 0.001), the cardiac index increased from 2.4 +/- 0.2 to 3.4 +/- 0.2 L/min/m2 (p less than 0.001), and the mean pulmonary artery pressure increased from 27 +/- 3 to 30 +/- 2 mm Hg (p less than 0.02). The pulmonary wedge pressure of 19 +/- 2 mm Hg and the mitral valve index of 0.8 +/- 0.1 cm2/m2 remained unchanged, but the left ventricular end-diastolic pressure decreased from 11 +/- 2 to 6 +/- 2 mm Hg (p less than 0.02). The hemodynamic response during the infusion of dobutamine identified a subgroup of patients with more severe mitral stenosis. Thus, the administration of dobutamine is useful in the evaluation of the severity of mitral valve obstruction during catheterization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3946174     DOI: 10.1016/0002-8703(86)90145-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  A new method of haemodynamic assessment of mitral stenosis in atrial fibrillation: construction of a nomogram.

Authors:  S W Davies; J E Gardener; T J Bowker; A D Timmis; R Balcon
Journal:  Br Heart J       Date:  1990-12

2.  Stress echocardiographic assessment of mitral valve function repaired using rough-zone trimming.

Authors:  Yohsuke Yanase; Nobuyuki Takagi; Hiroyuki Yamada; Toshitaka Watanabe; Mayuko Uehara; Kazutoshi Tachibana; Yasuko Miyaki; Toshiro Ito; Tetsuya Higami
Journal:  J Cardiothorac Surg       Date:  2015-02-28       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.